Inflammatory cytokines in bladder cancer
- 18 February 2019
- journal article
- review article
- Published by Wiley in Journal of Cellular Physiology
- Vol. 234 (9) , 14489-14499
Abstract
The presence of inflammatory cells and their products in the tumor microenvironment plays a crucial role in the pathogenesis of a tumor. Releasing the cytokines from a host in response to infection and inflammation can inhibit tumor growth and progression. However, tumor cells can also respond to the host cytokines with increasing the growth/invasion/metastasis. Bladder cancer (BC) is one of the most common cancers in the world. The microenvironment of a bladder tumor has been indicated to be rich in growth factors/inflammatory cytokines that can induce the tumor growth/progression and also suppress the immune system. On the contrary, modulate of the cancer progression has been shown following upregulation of the cytokines‐related pathways that suggested the cytokines as potential therapeutic targets. In this study, we provide a summary of cytokines that are involved in BC formation/regression with both inflammatory and anti‐inflammatory properties. A more accurate understanding of tumor microenvironment creates favorable conditions for cytokines targeting to treat BC.Keywords
Funding Information
- Tabriz University of Medical Sciences
This publication has 115 references indexed in Scilit:
- IL-6 Expression Regulates Tumorigenicity and Correlates with Prognosis in Bladder CancerPLOS ONE, 2013
- Mechanisms by Which Interleukin-6 Attenuates Cell Invasion and Tumorigenesis in Human Bladder Carcinoma CellsBioMed Research International, 2013
- IL-8 as a urinary biomarker for the detection of bladder cancerBMC Urology, 2012
- Interleukin-1 in the pathogenesis and treatment of inflammatory diseasesBlood, 2011
- Functional Specialization of Interleukin-17 Family MembersImmunity, 2011
- Involvement of T helper type 17 and regulatory T cell activity in tumour immunology of bladder carcinomaClinical and Experimental Immunology, 2010
- IL-17 can promote tumor growth through an IL-6–Stat3 signaling pathwayJournal of Experimental Medicine, 2009
- Tumor-specific Th17-polarized cells eradicate large established melanomaBlood, 2008
- The wolf in sheep's clothing: the role of interleukin-6 in immunity, inflammation and cancerTrends in Molecular Medicine, 2008
- Inflammation and cancerNature, 2002